Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study.

By E. Bonnefoy, F. Lapostolle, A. Leizorovicz, G. Steg, E. Mcfadden, P. Dubien, S. Cattan, Eric Boullenger, J. Machecourt, Jean-Micel Lacroute and 3 more. The Lancet, 2002

657 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/3bcd75f919f9f840838dbe72f03450612f7dbc06

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

Citations in the corpus

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2017, methodology): “When fibrinolysis is the reperfusion strategy, it is recommended to initiate this treatment as soon as possible after STEMI diagnosis, preferably in the pre-hospital setting.(96,98,123,222) I A”
Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. (2005, result): “These data are consistent with the CAPTIM study, with 1% (4/419) strokes in the thrombolysis and 0% (0/421) in the primary PCI group.(130) A meta-analysis focusing on the transfer trials revealed a significant 1.”
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013, result): “04).(123,142) These salutary results for early presenters were confirmed in a subsequent analysis of combined data from the CAPTIM and WEST (Which Early STElevation Myocardial Infarction Therapy) trials.”